Psyence Biomedical Ltd Stock Performance

PBM Stock  USD 2.56  0.33  14.80%   
The company holds a Beta of 3.03, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Psyence Biomedical will likely underperform. At this point, Psyence Biomedical has a negative expected return of -1.76%. Please make sure to check Psyence Biomedical's potential upside, rate of daily change, as well as the relationship between the Rate Of Daily Change and relative strength index , to decide if Psyence Biomedical performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Psyence Biomedical Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more

Actual Historical Performance (%)

One Day Return
14.8
Five Day Return
(3.03)
Year To Date Return
(48.80)
Ten Year Return
(99.99)
All Time Return
(99.99)
Last Split Factor
16:100
Last Split Date
2026-02-02
1
Concerns with Traditional PBM and Transparent Models Accelerates Demand for the First True Fiduciary PBM
12/17/2025
2
Calculating The Fair Value Of Pacific Booker Minerals Inc.
01/08/2026
3
Compugen vs. Psyence Biomedical Critical Survey
01/13/2026
4
MedCity Pivot Podcast Assessing the Hype and Healthcare Potential of AI and the Guardrails Needed to Prevent Medical Errors
01/14/2026
5
Psyence Biomedical Stock to Reverse Split on Tuesday, January 20th
01/16/2026
6
Rightway Eliminates Hidden Conflicts and Loopholes of Traditional PBM Pricing with SureSpend
01/21/2026
7
Psyence Biomedical announces 1-for-6.25 share consolidation By Investing.com - Investing.com Nigeria
01/28/2026
8
NCPA Cheers as Trump Signs First Major PBM Reform in Decades
02/03/2026
9
Psyence Biomedical Settles Shareholder Dispute With KAOS Capital - TipRanks
02/12/2026
10
Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders
02/17/2026
11
Psyence Biomedical shares rise following equity investment agreement - MSN
02/23/2026
Begin Period Cash Flow733.2 K
Total Cashflows From Investing Activities-16.2 K

Psyence Biomedical Relative Risk vs. Return Landscape

If you would invest  959.00  in Psyence Biomedical Ltd on November 28, 2025 and sell it today you would lose (703.00) from holding Psyence Biomedical Ltd or give up 73.31% of portfolio value over 90 days. Psyence Biomedical Ltd is generating negative expected returns assuming volatility of 9.1012% on return distribution over 90 days investment horizon. In other words, 81% of stocks are less volatile than Psyence, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Psyence Biomedical is expected to under-perform the market. In addition to that, the company is 11.95 times more volatile than its market benchmark. It trades about -0.19 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of volatility.

Psyence Biomedical Target Price Odds to finish over Current Price

The tendency of Psyence Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 2.56 90 days 2.56 
about 86.5
Based on a normal probability distribution, the odds of Psyence Biomedical to move above the current price in 90 days from now is about 86.5 (This Psyence Biomedical Ltd probability density function shows the probability of Psyence Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 3.03 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Psyence Biomedical will likely underperform. Additionally Psyence Biomedical Ltd has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Psyence Biomedical Price Density   
       Price  

Predictive Modules for Psyence Biomedical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Psyence Biomedical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.183.6912.79
Details
Intrinsic
Valuation
LowRealHigh
0.122.4611.56
Details
Naive
Forecast
LowNextHigh
0.073.2512.35
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-9.712.633.25
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Psyence Biomedical. Your research has to be compared to or analyzed against Psyence Biomedical's peers to derive any actionable benefits. When done correctly, Psyence Biomedical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Psyence Biomedical.

Psyence Biomedical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Psyence Biomedical is not an exception. The market had few large corrections towards the Psyence Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Psyence Biomedical Ltd, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Psyence Biomedical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-2.65
β
Beta against Dow Jones3.03
σ
Overall volatility
3.20
Ir
Information ratio -0.25

Psyence Biomedical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Psyence Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Psyence Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Psyence Biomedical generated a negative expected return over the last 90 days
Psyence Biomedical has high historical volatility and very poor performance
Psyence Biomedical has a very high chance of going through financial distress in the upcoming years
Psyence Biomedical Ltd has about 281.63 K in cash with (3.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Latest headline from news.google.com: Psyence Biomedical shares rise following equity investment agreement - MSN

Psyence Biomedical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Psyence Stock often depends not only on the future outlook of the current and potential Psyence Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Psyence Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding568 K
Cash And Short Term Investments6.1 M

Psyence Biomedical Fundamentals Growth

Psyence Stock prices reflect investors' perceptions of the future prospects and financial health of Psyence Biomedical, and Psyence Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Psyence Stock performance.

About Psyence Biomedical Performance

By examining Psyence Biomedical's fundamental ratios, stakeholders can obtain critical insights into Psyence Biomedical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Psyence Biomedical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.16  0.17 
Return On Capital Employed(0.63)(0.60)
Return On Assets 0.16  0.17 
Return On Equity 0.14  0.13 

Things to note about Psyence Biomedical performance evaluation

Checking the ongoing alerts about Psyence Biomedical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Psyence Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Psyence Biomedical generated a negative expected return over the last 90 days
Psyence Biomedical has high historical volatility and very poor performance
Psyence Biomedical has a very high chance of going through financial distress in the upcoming years
Psyence Biomedical Ltd has about 281.63 K in cash with (3.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Latest headline from news.google.com: Psyence Biomedical shares rise following equity investment agreement - MSN
Evaluating Psyence Biomedical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Psyence Biomedical's stock performance include:
  • Analyzing Psyence Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Psyence Biomedical's stock is overvalued or undervalued compared to its peers.
  • Examining Psyence Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Psyence Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Psyence Biomedical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Psyence Biomedical's stock. These opinions can provide insight into Psyence Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Psyence Biomedical's stock performance is not an exact science, and many factors can impact Psyence Biomedical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Psyence Biomedical is a strong investment it is important to analyze Psyence Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psyence Biomedical's future performance. For an informed investment choice regarding Psyence Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Will Biotechnology sector continue expanding? Could Psyence diversify its offerings? Factors like these will boost the valuation of Psyence Biomedical. Anticipated expansion of Psyence directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Psyence Biomedical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(389.98)
Return On Assets
(0.34)
Return On Equity
(0.74)
Psyence Biomedical's market price often diverges from its book value, the accounting figure shown on Psyence's balance sheet. Smart investors calculate Psyence Biomedical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Psyence Biomedical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Psyence Biomedical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Psyence Biomedical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.